INHIBITION OF CELL SURVIVAL, TUMOR GROWTH AND HISTONE DEACETYLASE (HDAC) ACTIVITY BY THE DIETARY FLAVONOID LUTEOLIN IN HUMAN EPITHELIOID CANCER CELLS

被引：0
|
作者：
Iratni, R.
Attoub, S. [1 ]
Hassan, A. H. [1 ]
Vanhoecke, B. [2 ]
Gaben, A. M. [3 ]
Bracke, M. [4 ]
Al-Sultan, M.
Arafat, K.
Gespach, C. [3 ]
Petroianu, G. [1 ]
机构：
[1] UAE Univ, Fac Med & Hlth Sci, Al Ain, U Arab Emirates
[2] Univ Hosp Pintelaan, Lab Expt Canc Res, Ghent, Belgium
[3] Univ Paris 06, INSERM, U673, U938, Paris, France
[4] Univ Hosp Pintelaan, Lab Expt Canc Res, Ghent, Belgium
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S114 / S114
页数：1
相关论文
共 50 条
  • [31] Inhibition of Histone Deacetylase (HDAC) Enhances Checkpoint Blockade Efficacy by Rendering Bladder Cancer Cells Visible for T Cell-Mediated Destruction
    Burke, Brianna
    Eden, Catherine
    Perez, Cynthia
    Belshoff, Alex
    Hart, Spencer
    Plaza-Rojas, Lourdes
    Delos Reyes, Michael
    Prajapati, Kushal
    Voelkel-Johnson, Christina
    Henry, Elizabeth
    Gupta, Gopal
    Guevara-Patino, Jose
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [32] Synergistic anti-tumor effect by a combination treatment with the dietary flavonoid luteolin and the chemotherapy drugs Tasigna or Adrucil in human pancreatic cancer cells
    Aksamitiene, Edita
    Achanta, Sirisha
    Kiyatkin, Anatoly
    Hoek, Jan B.
    FASEB JOURNAL, 2012, 26
  • [33] Inhibition of histone deacetylase 6 attenuated lung cancer growth via suppression of ERK activity
    Wattanathamsan, Onsurang
    Pongrakhananon, Varisa
    CANCER SCIENCE, 2023, 114 : 2053 - 2053
  • [34] Histone Deacetylase 6 (HDAC6) Influences T-Cell Activation and Survival: Implications For Cancer Immunotherapy
    Laino, Andressa Sodre
    Woods, David M.
    Cheng, Fengdong
    Wang, Hongwei
    Sotomayor, Eduardo M.
    BLOOD, 2013, 122 (21)
  • [35] Histone deacetylase inhibitor BML-210 induces growth inhibition and apoptosis and regulates HDAC and DAPC complex expression levels in cervical cancer cells
    Borutinskaite, Veronika V.
    Magnusson, Karl-Eric
    Navakauskiene, Ruta
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (12) : 10179 - 10186
  • [36] Anti-tumor activity of histone deacetylase inhibitor FK228 (depsipeptide) for human prostate cancer cells
    Chen, W. C.
    Lai, M. T.
    Tsai, F. J.
    Lin, T. Y.
    Yang, C. C.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 82 - 82
  • [37] Histone deacetylase inhibitor BML-210 induces growth inhibition and apoptosis and regulates HDAC and DAPC complex expression levels in cervical cancer cells
    Veronika V. Borutinskaite
    Karl-Eric Magnusson
    Ruta Navakauskiene
    Molecular Biology Reports, 2012, 39 : 10179 - 10186
  • [38] Histone deacetylase 3 overexpression in human cholangiocarcinoma and promotion of cell growth via apoptosis inhibition
    Yin, Yuyao
    Zhang, Mingming
    Dorfman, Robert Gregory
    Li, Yang
    Zhao, Zhenguo
    Pan, Yida
    Zhou, Qian
    Huang, Shan
    Zhao, Shimin
    Yao, Yuling
    Zou, Xiaoping
    CELL DEATH & DISEASE, 2017, 8 : e2856 - e2856
  • [39] Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824
    Atadja, P
    Gao, L
    Kwon, P
    Trogani, N
    Walker, H
    Hsu, M
    Yeleswarapu, L
    Chandramouli, N
    Perez, L
    Versace, R
    Wu, A
    Sambucetti, L
    Lassota, P
    Cohen, D
    Bair, K
    Wood, A
    Remiszewski, S
    CANCER RESEARCH, 2004, 64 (02) : 689 - 695
  • [40] Histone deacetylase 3 overexpression in human cholangiocarcinoma and promotion of cell growth via apoptosis inhibition
    Yuyao Yin
    Mingming Zhang
    Robert Gregory Dorfman
    Yang Li
    Zhenguo Zhao
    Yida Pan
    Qian Zhou
    Shan Huang
    Shimin Zhao
    Yuling Yao
    Xiaoping Zou
    Cell Death & Disease, 2017, 8 : e2856 - e2856
12345